Antibody titers against the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 induced by BNT162b2 vaccination measured using automated chemiluminescent enzyme immunoassay
Hideaki Kato, Kei Miyakawa, Norihisa Ohtake, Hirofumi Go, Yutaro Yamaoka, Satoshi Yajima, Tomoko Shimada, Atsushi Goto, Hideaki Nakajima, Akihide Ryo
doi: https://doi.org/10.1101/2021.09.23.21263927
Hideaki Kato
1Infection Prevention and Control Department, Yokohama City University Hospital, Yokohama, Japan
2Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan
Kei Miyakawa
3Department of Microbiology, Yokohama City University School of Medicine, Yokohama, Japan
Norihisa Ohtake
4Bioscience Division, Research and Development Department, Tosoh Corporation, Tokyo Research Center, Kanagawa, Japan
5Advanced Medical Research Center, Yokohama City University, Yokohama, Japan
Hirofumi Go
6Department of Biostatistics, Yokohama City University Graduate School of Medicine, Yokohama, Japan
Yutaro Yamaoka
3Department of Microbiology, Yokohama City University School of Medicine, Yokohama, Japan
7Life Science Laboratory, Technology and Development Division, Kanto Chemical Co, Inc., Isehara, Japan
Satoshi Yajima
8Clinical Laboratory Department, Yokohama City University Hospital, Yokohama, Japan
Tomoko Shimada
9Nursing Department, Yokohama City University Hospital, Yokohama, Japan
Atsushi Goto
10Department of Health Data Science, Yokohama City University Graduate School of Data Science, Yokohama, Japan
Hideaki Nakajima
2Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan
Akihide Ryo
3Department of Microbiology, Yokohama City University School of Medicine, Yokohama, Japan
Data Availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Posted September 26, 2021.
Antibody titers against the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 induced by BNT162b2 vaccination measured using automated chemiluminescent enzyme immunoassay
Hideaki Kato, Kei Miyakawa, Norihisa Ohtake, Hirofumi Go, Yutaro Yamaoka, Satoshi Yajima, Tomoko Shimada, Atsushi Goto, Hideaki Nakajima, Akihide Ryo
medRxiv 2021.09.23.21263927; doi: https://doi.org/10.1101/2021.09.23.21263927
Antibody titers against the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 induced by BNT162b2 vaccination measured using automated chemiluminescent enzyme immunoassay
Hideaki Kato, Kei Miyakawa, Norihisa Ohtake, Hirofumi Go, Yutaro Yamaoka, Satoshi Yajima, Tomoko Shimada, Atsushi Goto, Hideaki Nakajima, Akihide Ryo
medRxiv 2021.09.23.21263927; doi: https://doi.org/10.1101/2021.09.23.21263927
Subject Area
Subject Areas
- Addiction Medicine (395)
- Allergy and Immunology (707)
- Anesthesia (198)
- Cardiovascular Medicine (2899)
- Dermatology (249)
- Emergency Medicine (435)
- Epidemiology (12660)
- Forensic Medicine (10)
- Gastroenterology (816)
- Genetic and Genomic Medicine (4514)
- Geriatric Medicine (411)
- Health Economics (721)
- Health Informatics (2885)
- Health Policy (1061)
- Hematology (381)
- HIV/AIDS (916)
- Medical Education (419)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4279)
- Nursing (231)
- Nutrition (629)
- Oncology (2244)
- Ophthalmology (638)
- Orthopedics (256)
- Otolaryngology (323)
- Pain Medicine (274)
- Palliative Medicine (83)
- Pathology (492)
- Pediatrics (1187)
- Primary Care Research (491)
- Public and Global Health (6861)
- Radiology and Imaging (1508)
- Respiratory Medicine (912)
- Rheumatology (432)
- Sports Medicine (379)
- Surgery (478)
- Toxicology (60)
- Transplantation (206)
- Urology (177)